DOI: 10.1055/s-00000133

Gastroenterologie up2date

References

Giantonio BJ, Catalano PJ, Meropol NJ.
High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200. 
ASCO 2005; Abstract: 2-  

Download Bibliographical Data

Search in: